Insider · CIK 0001609284

Saccomano Nicholas A

Reports to the SEC for 2 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001609284

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-21	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−87 sh	$2.97	−$258.755	11,160
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+150K sh	—	—	150,000
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−2,359 sh	—	—	0
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+2,359 sh	—	—	2,359
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1,485 sh	—	—	0
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1,485 sh	—	—	1,485
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−8,449 sh	—	—	0
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+8,449 sh	—	—	8,449
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−16.9K sh	—	—	0
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+16.9K sh	—	—	16,898
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−542K sh	—	—	0
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+542K sh	—	—	542,232
2026-06-22	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−86 sh	$4.40	−$378.082	11,247
2026-04-01	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+330K sh	—	—	330,000
2026-03-23	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−86 sh	$4.16	−$357.459	7,333
2025-12-22	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−87 sh	$2.97	−$258.19	7,419
2025-09-22	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−88 sh	$2.62	−$230.868	3,506
2025-06-23	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−88 sh	$2.38	−$209.81	3,594
2025-04-07	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−516 sh	$2.67	−$1,378.236	3,682
2025-04-04	OKUROnKure Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−358 sh	$3.33	−$1,191.281	4,198
2025-01-27	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+130K sh	—	—	130,000
2024-10-04	OKUROnKure Therapeutics, Inc.A Award	Director, President and CEO	AAward	+4,556 sh	—	—	4,556
2024-10-04	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+2,359 sh	—	—	2,359
2024-10-04	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1,485 sh	—	—	1,485
2024-10-04	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+16.9K sh	—	—	16,898
2024-10-04	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+8,449 sh	—	—	8,449
2024-10-04	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+542K sh	—	—	542,232
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	CSO	DDisposition to Issuer	−150K sh	$48.00	−$7.21M	61,813
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	CSO	DDisposition to Issuer	−61.8K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−165K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−82.5K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−131K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−168K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CSO	DDisposition to Issuer	−138K sh	—	—	0
2019-04-01	ARRAY BIOPHARMA INCM Exercise/Conversion	CSO	MExercise/Conversion	+13.8K sh	—	—	156,238
2019-04-01	ARRAY BIOPHARMA INCF Tax Payment	CSO	FTax Payment	−6,048 sh	$24.60	−$149K	150,190
2019-04-01	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	CSO	MExercise/Conversion	−6,875 sh	—	—	0
2019-04-01	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	CSO	MExercise/Conversion	−6,875 sh	—	—	6,875
2019-02-07	ARRAY BIOPHARMA INCM Exercise/Conversion	CSO	MExercise/Conversion	+82.5K sh	$3.00	+$248K	224,988
2019-02-07	ARRAY BIOPHARMA INCM Exercise/Conversion	CSO	MExercise/Conversion	+105K sh	$4.20	+$440K	329,752
2019-02-07	ARRAY BIOPHARMA INCS Sale	CSO	SSale	−187K sh	$21.58	−$4.04M	142,488
2019-02-07	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	CSO	MExercise/Conversion	−105K sh	—	—	0
2019-02-07	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	CSO	MExercise/Conversion	−82.5K sh	—	—	82,500
2019-01-31	ARRAY BIOPHARMA INCM Exercise/Conversion	CSO	MExercise/Conversion	+95.2K sh	$4.20	+$400K	163,913
2019-01-31	ARRAY BIOPHARMA INCF Tax Payment	CSO	FTax Payment	−21.4K sh	$18.67	−$400K	142,488
2019-01-31	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	CSO	MExercise/Conversion	−95.2K sh	—	—	104,764
2018-12-16	ARRAY BIOPHARMA INCM Exercise/Conversion	CSO	MExercise/Conversion	+12.5K sh	—	—	74,162
2018-12-16	ARRAY BIOPHARMA INCF Tax Payment	CSO	FTax Payment	−5,485 sh	$15.97	−$87.6K	68,677
2018-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	CSO	MExercise/Conversion	−5,469 sh	—	—	10,938
2018-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	CSO	MExercise/Conversion	−7,000 sh	—	—	21,000

Recent filings

Accepted (ET)
Sep 234
Saccomano Nicholas A0001609284-26-000005
SEC(opens sec.gov)
Aug 114
Saccomano Nicholas A0001609284-26-000004
SEC(opens sec.gov)
Jun 244
Saccomano Nicholas A0001609284-26-000003
SEC(opens sec.gov)
Apr 34
Saccomano Nicholas A0001609284-26-000002
SEC(opens sec.gov)
Mar 244
Saccomano Nicholas A0001609284-26-000001
SEC(opens sec.gov)
Dec 234
Saccomano Nicholas A0001609284-25-000004
SEC(opens sec.gov)
Sep 244
Saccomano Nicholas A0001609284-25-000003
SEC(opens sec.gov)
Jun 254
Saccomano Nicholas A0001415889-25-018235
SEC(opens sec.gov)
Apr 84
Saccomano Nicholas A0001415889-25-010419
SEC(opens sec.gov)

Companies

Address

C/O ONKURE THERAPEUTICS, INC. 6707 WINCHESTER CIRCLE, SUITE 400

BOULDER, CO, 80301